Halozyme Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
14 Aug 24 | Sell€1,532,020 | Matthew Posard | Individual | 29,881 | €52.33 | |
12 Jun 24 | Sell€927,708 | Matthew Posard | Individual | 20,000 | €46.67 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 60,275 | 0.0466% |
Individual Insiders | 1,274,233 | 0.984% |
Institutions | 128,138,554 | 99% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
17,430,019 | €820.2m | -1.08% | 0.01% | |||
12,895,096 | €606.8m | 0.11% | 0.01% | |||
6,633,688 | €312.1m | 14.1% | 0.01% | |||
4,063,367 | €191.2m | 0.58% | 3.75% | |||
3,408,341 | €160.4m | -3.97% | 0.05% | |||
3,133,412 | €147.4m | -15.7% | 0.11% | |||
3,060,131 | €144.0m | 1.02% | 0.01% | |||
3,010,825 | €141.7m | -2.17% | 0.16% | |||
2,525,184 | €118.8m | -2.38% | 0.01% | |||
2,433,579 | €114.5m | 446% | 0.72% | |||
2,010,655 | €94.6m | -3.83% | 1.13% | |||
1,969,169 | €92.7m | 76.9% | 0.13% | |||
1,885,765 | €88.7m | -0.63% | 0.01% | |||
1,773,397 | €83.4m | -0.79% | 0.01% | |||
1,762,261 | €82.9m | -19.2% | 0.63% | |||
1,682,154 | €79.2m | -6.34% | 0.01% | |||
1,656,213 | €77.9m | -15.6% | 0.02% | |||
1,550,736 | €73.0m | -34.5% | 0.05% | |||
1,539,153 | €72.4m | 6.72% | 0.02% | |||
1,464,787 | €68.9m | 223% | 0.03% | |||
1,359,730 | €64.0m | -4.37% | 0.81% | |||
1,270,521 | €59.8m | -2.39% | no data | |||
1,269,827 | €59.8m | 50.1% | 0.47% | |||
1,216,161 | €57.2m | 0% | no data | |||
1,082,359 | €50.9m | 42.1% | 0.01% |